SEC Charges Biotech Co. with Misleading IPO Investors
On September 13, the SEC charged Zymergen Inc., a biotechnology company, with misleading IPO investors about the company’s market...
SEC Charges Biotech Co. with Misleading IPO Investors
On September 13, the SEC charged Zymergen Inc., a biotechnology company, with misleading IPO investors about the company’s market...